Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $35.48B | $320.30 | $390.88 | 22.03% | Strong Buy | 8 | 128.29% | 1,035.17% | 3,703.46% | 2,003.62% | |||
| NVO | NOVO NORDISK A S | $244.88B | $55.11 | $57.40 | 4.16% | Buy | 5 | 96.31% | 97.21% | 501.77% | 166.41% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $52.56B | $397.83 | $491.28 | 23.49% | Strong Buy | 25 | 37.32% | 307.74% | 1,650.79% | 79.58% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.11B | $41.06 | $51.33 | 25.02% | Strong Buy | 6 | 25.55% | 80.85% | 41.88% | 31.47% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $469.52M | $8.34 | $22.00 | 163.79% | Strong Buy | 3 | 53.54% | 77.67% | 139.83% | 68.93% | |||
| CORT | CORCEPT THERAPEUTICS INC | $3.68B | $34.95 | $101.25 | 189.70% | Strong Buy | 4 | 44.80% | 101.92% | 128.08% | 98.27% | |||
| VCEL | VERICEL CORP | $1.88B | $37.08 | $51.50 | 38.89% | Strong Buy | 2 | 21.63% | 84.43% | 29.97% | 21.28% | |||
| ARGX | ARGENX SE | $48.88B | $800.88 | $1.03k | 28.23% | Strong Buy | 15 | 1,549.26% | 23.80% | 54.36% | 46.18% | |||
| KRYS | KRYSTAL BIOTECH INC | $7.10B | $244.71 | $217.80 | -11.00% | Buy | 5 | 36.80% | 30.09% | 75.26% | 69.06% | |||
| TECH | BIO-TECHNE CORP | $9.82B | $63.03 | $69.22 | 9.82% | Strong Buy | 9 | 6.53% | 73.19% | 22.68% | 17.65% | |||
| GMAB | GENMAB A | $20.42B | $31.80 | $43.75 | 37.58% | Strong Buy | 4 | 16.73% | 133.44% | 30.51% | 24.99% | |||
| ABEO | ABEONA THERAPEUTICS INC | $282.88M | $5.22 | $20.00 | 283.14% | Buy | 2 | 817.16% | 17.10% | 81.99% | 60.75% | |||
| ADMA | ADMA BIOLOGICS INC | $4.29B | $18.03 | N/A | N/A | N/A | N/A | 27.01% | 23.78% | 114.85% | 87.08% | |||
| XOMA | XOMA ROYALTY CORP | $329.64M | $26.62 | $72.67 | 172.98% | Strong Buy | 3 | 41.58% | 37.69% | N/A | N/A | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.02B | $15.30 | $17.25 | 12.75% | Buy | 4 | 20.04% | 30.63% | 46.23% | 32.06% | |||
| VCYT | VERACYTE INC | $3.45B | $43.63 | $46.33 | 6.20% | Buy | 6 | 13.01% | 70.57% | 14.91% | 13.71% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $3.78B | $192.03 | $243.50 | 26.80% | Strong Buy | 6 | 14.25% | 69.75% | 24.08% | 15.49% | |||
| CRMD | CORMEDIX INC | $960.44M | $12.19 | $18.40 | 50.94% | Buy | 5 | 29.70% | 5.75% | 70.46% | 35.11% | |||
| MNKD | MANNKIND CORP | $1.73B | $5.62 | $10.08 | 79.41% | Strong Buy | 6 | 21.75% | 60.18% | -453.45% | 40.84% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $514.75M | $6.45 | $13.00 | 101.55% | Strong Buy | 2 | 23.38% | 31.11% | 72.56% | 52.26% | |||
| RPRX | ROYALTY PHARMA PLC | $22.89B | $39.65 | $45.75 | 15.38% | Strong Buy | 4 | 18.58% | 57.53% | 40.57% | 20.18% | |||
| EXEL | EXELIXIS INC | $11.37B | $42.40 | $44.94 | 5.99% | Buy | 16 | 13.01% | 24.88% | 71.97% | 55.08% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $113.87B | $448.80 | $490.06 | 9.19% | Buy | 18 | 10.80% | 20.63% | 41.92% | 29.20% | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $143.95M | $1.79 | $12.00 | 570.39% | Buy | 1 | 15.12% | 152.57% | 29.17% | 18.76% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.31B | $58.87 | $86.91 | 47.63% | Strong Buy | 11 | 8.93% | 35.89% | 24.27% | 19.30% | |||
| APLS | APELLIS PHARMACEUTICALS INC | $3.15B | $24.87 | $36.77 | 47.84% | Buy | 13 | 7.81% | 36.38% | 57.08% | 21.63% | |||
| HALO | HALOZYME THERAPEUTICS INC | $8.37B | $71.20 | $77.13 | 8.32% | Buy | 8 | 18.07% | 29.40% | 223.75% | 50.76% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.12B | $36.75 | $45.00 | 22.45% | Strong Buy | 6 | 16.87% | 36.05% | 77.91% | 53.85% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.80B | $22.80 | $33.00 | 44.74% | Strong Buy | 1 | 9.04% | 18.84% | 57.36% | 50.19% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $80.22B | $763.23 | $787.63 | 3.20% | Buy | 16 | 8.17% | 10.23% | 22.36% | 17.24% | |||
| MDXG | MIMEDX GROUP INC | $937.49M | $6.33 | $11.00 | 73.78% | Strong Buy | 2 | 14.25% | 33.63% | N/A | N/A | |||
| INVA | INNOVIVA INC | $1.50B | $20.03 | $32.25 | 61.01% | Buy | 4 | 10.65% | 12.32% | 25.83% | 18.25% | |||
| UTHR | UNITED THERAPEUTICS CORP | $21.08B | $489.69 | $495.08 | 1.10% | Buy | 12 | 11.18% | 8.41% | 27.79% | 24.91% | |||
| ACAD | ACADIA PHARMACEUTICALS INC | $4.42B | $26.15 | $31.08 | 18.86% | Buy | 12 | 12.14% | 5.80% | 46.60% | 32.12% | |||
| INCY | INCYTE CORP | $19.98B | $101.79 | $98.63 | -3.11% | Buy | 16 | 10.30% | 19.27% | 19.99% | 14.69% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.